IL22RA2 and lung carcinoma: This finding prompted one to further study whether DEIRGs between high- and low-mRNAsi subtypes enriched in JAK/STAT pathway (CNTFR, CRLF2, CSF2, IL12B, IL2, and IL22RA2 in LUAD) affect stemness in lung cancer.